These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17384320)

  • 1. Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease.
    Bottiggi KA; Salazar JC; Yu L; Caban-Holt AM; Ryan M; Schmitt FA
    Am J Geriatr Psychiatry; 2007 Apr; 15(4):357-9. PubMed ID: 17384320
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing the tolerability of tacrine with propantheline.
    Faber RA; Negro PJ
    Am J Psychiatry; 1999 Jan; 156(1):156. PubMed ID: 9892315
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of anticholinergic drugs and cholinesterase inhibitors and their association with psychological well-being among frail older adults in residential care facilities.
    Teramura-Grönblad M; Muurinen S; Soini H; Suominen M; Pitkälä KH
    Ann Pharmacother; 2011 May; 45(5):596-602. PubMed ID: 21562310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.
    Robinson M; Rowett D; Leverton A; Mabbott V
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk/benefit assessment in the treatment of Alzheimer's disease. Drug interactions].
    Hernández-Arroyo MJ; Díaz-Madero A
    Rev Esp Geriatr Gerontol; 2016; 51(4):191-5. PubMed ID: 26775172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.
    Koontz J; Baskys A
    Am J Alzheimers Dis Other Demen; 2005; 20(5):295-302. PubMed ID: 16273995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease.
    Lu CJ; Tune LE
    Am J Geriatr Psychiatry; 2003; 11(4):458-61. PubMed ID: 12837675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors and anticholinergic drugs: is the pharmacologic antagonism myth or reality?
    Beier MT
    J Am Med Dir Assoc; 2005; 6(6):413-4. PubMed ID: 16286067
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term cognitive impact of anticholinergic medications in older adults.
    Bottiggi KA; Salazar JC; Yu L; Caban-Holt AM; Ryan M; Mendiondo MS; Schmitt FA
    Am J Geriatr Psychiatry; 2006 Nov; 14(11):980-4. PubMed ID: 17068321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with cholinesterase inhibitors.
    Defilippi JL; Crismon ML
    Drugs Aging; 2003; 20(6):437-44. PubMed ID: 12710863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating Alzheimer's disease with cholinesterase inhibitors: what have we learned so far?
    Feldman H
    Int Psychogeriatr; 2002; 14 Suppl 1():3-5. PubMed ID: 12636177
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
    Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
    J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
    Rodda J; Carter J
    Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
    [No Abstract]   [Full Text] [Related]  

  • 14. Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes.
    Modi A; Weiner M; Craig BA; Sands LP; Rosenman MB; Thomas J
    J Am Geriatr Soc; 2009 Jul; 57(7):1238-44. PubMed ID: 19467148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Alzheimer disease.
    Winslow BT; Onysko MK; Stob CM; Hazlewood KA
    Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should one stop cholinesterase inhibitors in patients with Alzheimer's disease?
    Bogardus ST
    J Psychiatry Neurosci; 2001 Nov; 26(5):425. PubMed ID: 11762210
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and validation of a composite score as an easy-to-use instrument for clinical monitoring of dementia progression: the Composite Cognitive and Activities of Daily Living Functioning Score.
    Melis RJ; Angleman SB; Fratiglioni L
    J Am Geriatr Soc; 2011 Jun; 59(6):1154-5. PubMed ID: 21668928
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients.
    Valladales-Restrepo LF; Duran-Lengua M; Machado-Alba JE
    Geriatr Gerontol Int; 2019 Sep; 19(9):913-917. PubMed ID: 31342625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 20. A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors.
    Jones RW
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):547-53. PubMed ID: 20049770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.